Udho Thadani to Middle Aged
This is a "connection" page, showing publications Udho Thadani has written about Middle Aged.
Connection Strength
0.752
-
Prognostic Value of 6-Minute Walk Distance in Patients Undergoing Percutaneous Coronary Intervention: a Veterans Affairs Prospective Study. Tex Heart Inst J. 2020 02; 47(1):10-14.
Score: 0.078
-
Is risk factor control and guideline-based medical therapy optimal in patients with nonobstructive coronary artery disease? A Veterans Affairs study. Am J Med Sci. 2013 May; 345(5):339-42.
Score: 0.049
-
Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function. Am J Med Sci. 2013 Mar; 345(3):211-7.
Score: 0.048
-
Exercise performance, physical activity, and health-related quality of life in participants with stable angina. Angiology. 2011 Aug; 62(6):461-6.
Score: 0.042
-
Therapy of stable angina pectoris: the uncomplicated patient. Circulation. 2005 Oct 11; 112(15):e255-9.
Score: 0.029
-
The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. J Am Coll Cardiol. 2002 Dec 04; 40(11):2006-12.
Score: 0.024
-
Lack of arrhythmogenicity with ST-segment elevation during high-dose of dobutamine atropine stress in patients with documented or suspected coronary artery disease. Am J Cardiol. 1997 Aug 01; 80(3):341-3.
Score: 0.016
-
Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris. Am J Cardiol. 1997 Apr 15; 79(8):1025-30.
Score: 0.016
-
Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry. JACC Heart Fail. 2016 05; 4(5):348-56.
Score: 0.015
-
Management Strategies and Outcomes of ST-Segment Elevation Myocardial Infarction Patients Transferred After Receiving Fibrinolytic Therapy in the United States. Clin Cardiol. 2016 Jan; 39(1):9-18.
Score: 0.015
-
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group. Circulation. 1994 Aug; 90(2):726-34.
Score: 0.013
-
Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST) Circulation. 1994 Aug; 90(2):762-8.
Score: 0.013
-
Duration of effects of isradipine during twice daily therapy in angina pectoris. Cardiovasc Drugs Ther. 1994 Apr; 8(2):199-210.
Score: 0.013
-
Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate. Ann Intern Med. 1994 Mar 01; 120(5):353-9.
Score: 0.013
-
Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction. J Am Heart Assoc. 2013 Aug 21; 2(4):e000214.
Score: 0.012
-
Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function. Clin Cardiol. 2013 Oct; 36(10):611-20.
Score: 0.012
-
Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris. Am J Cardiol. 1992 Aug 01; 70(3):286-92.
Score: 0.012
-
Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris. Circulation. 1991 Dec; 84(6):2398-408.
Score: 0.011
-
Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Circulation. 2011 Oct 25; 124(17):1811-8.
Score: 0.011
-
A multicenter comparison of isradipine and prazosin for treatment of essential hypertension. Cardiovasc Drugs Ther. 1990 Apr; 4(2):413-7.
Score: 0.010
-
Amlodipine: a once-daily calcium antagonist in the treatment of angina pectoris--a parallel dose-response, placebo-controlled study. The Amlodipine Study Group. Am Heart J. 1989 Nov; 118(5 Pt 2):1135.
Score: 0.010
-
Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Am Heart J. 2009 Oct; 158(4 Suppl):S72-7.
Score: 0.009
-
Long-term bepridil monotherapy for angina pectoris. Am J Cardiol. 1988 Jun 01; 61(15):1210-3.
Score: 0.009
-
Amlodipine--a once-daily calcium antagonist in the treatment of angina pectoris: a parallel dose-response placebo-controlled study. J Cardiovasc Pharmacol. 1988; 12 Suppl 7:S114.
Score: 0.008
-
Noninvasive evaluation of aortic stenosis severity utilizing Doppler ultrasound and electrical bioimpedance. J Am Coll Cardiol. 1988 Jan; 11(1):66-71.
Score: 0.008
-
Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care. 2008 Feb; 31(2):353-60.
Score: 0.008
-
Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris. Am J Cardiol. 1987 Sep 01; 60(7):477-82.
Score: 0.008
-
Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy. Clin Pharmacol Ther. 1987 Jul; 42(1):58-65.
Score: 0.008
-
Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris. Am J Cardiol. 1987 Apr 01; 59(8):756-62.
Score: 0.008
-
Clinically silent atrial septal defects with evidence for cerebral embolization. Ann Intern Med. 1986 Nov; 105(5):695-7.
Score: 0.008
-
Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance. Ann Intern Med. 1986 Oct; 105(4):485-92.
Score: 0.008
-
Quantification of aortic regurgitation utilizing continuous wave Doppler ultrasound. J Am Coll Cardiol. 1986 Sep; 8(3):592-9.
Score: 0.008
-
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2006 Sep; 48(3):374-84.
Score: 0.008
-
Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. J Am Coll Cardiol. 2005 Nov 15; 46(10):1803-11.
Score: 0.007
-
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2005 Jun 27; 165(12):1401-9.
Score: 0.007
-
Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris. Am J Cardiol. 1985 Mar 15; 55(7):36C-42C.
Score: 0.007
-
Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial. J Am Coll Cardiol. 2003 Dec 17; 42(12):2049-59.
Score: 0.006
-
Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina. Eur Heart J. 2003 Dec; 24(24):2206-12.
Score: 0.006
-
Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris. Am J Cardiol. 2003 Feb 01; 91(3):274-9.
Score: 0.006
-
Interaction of indomethacin and nitroglycerin on hemodynamics and exercise tolerance in patients with angina pectoris. Z Kardiol. 1983; 72 Suppl 3:35-9.
Score: 0.006
-
Usefulness of clinical information to distinguish patients with normal from those with low ejection fractions in heart failure. Am J Cardiol. 2002 May 15; 89(10):1218-21.
Score: 0.006
-
Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy. Am J Cardiol. 1982 Feb 01; 49(2):411-9.
Score: 0.006
-
Comparison of pharmacokinetics of lanoteplase and alteplase during acute myocardial infarction. Clin Pharmacokinet. 2002; 41(6):445-52.
Score: 0.006
-
Hemodynamic effects of disopyramide at rest and during exercise in normal subjects. Cathet Cardiovasc Diagn. 1981; 7(1):27-34.
Score: 0.005
-
Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy. Circulation. 1980 Sep; 62(3):491-502.
Score: 0.005
-
Propranolol in angina pectoris: comparison of therapy given two and four times daily. Am J Cardiol. 1980 Jul; 46(1):117-23.
Score: 0.005
-
Are the clinical and hemodynamic events during exercise stress testing in invasive studies in patients with angina pectoris reproducible? Circulation. 1980 Apr; 61(4):744-50.
Score: 0.005
-
Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate. Circulation. 1980 Mar; 61(3):526-35.
Score: 0.005
-
Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris. Am J Med. 1980 Feb; 68(2):243-50.
Score: 0.005
-
Reproducibility of clinical and hemodynamic parameters during pacing stress testing in patients with angina pectoris. Circulation. 1979 Nov; 60(5):1036-44.
Score: 0.005
-
Cardiac performance at rest and during exercise in normal subjects. Bull Eur Physiopathol Respir. 1979 Sep-Oct; 15(5):935-49.
Score: 0.005
-
Clinical, hemodynamic and metabolic responses during pacing in the supine and sitting postures in patients with angina pectoris. Am J Cardiol. 1979 Aug; 44(2):249-56.
Score: 0.005
-
Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration. Am J Cardiol. 1979 Jul; 44(1):118-25.
Score: 0.005
-
Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris. N Engl J Med. 1979 Apr 05; 300(14):750-5.
Score: 0.005
-
Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy. Circulation. 1979 Mar; 59(3):571-9.
Score: 0.005
-
Effects of glucose-insulin-potassium infusion on the angina response during treadmill exercise. Cardiology. 1979; 64(6):333-49.
Score: 0.004
-
Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase. Circulation. 1998 Nov 17; 98(20):2117-25.
Score: 0.004
-
Influence of glyceryl trinitrate during supine and upright exercise in patients with angina pectoris. Br Heart J. 1978 Nov; 40(11):1229-36.
Score: 0.004
-
Hemodynamics at rest and during supine and sitting bicycle exercise in normal subjects. Am J Cardiol. 1978 Jan; 41(1):52-9.
Score: 0.004
-
Hemodynamics at rest and during supine and sitting bicycle exercise in patients with coronary artery disease. Am J Cardiol. 1977 May 26; 39(6):776-83.
Score: 0.004
-
Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris. Zatebradine Investigators. Am J Cardiol. 1997 May 15; 79(10):1401-5.
Score: 0.004
-
Comparative anti-hypertensive effectiveness of beta-adrenoreceptor antagonists with different pharmacological properties: dose-response studies during acute and chronic administration. Clin Sci Mol Med Suppl. 1976 Dec; 3:541s-544s.
Score: 0.004
-
Cardiac tamponade, constrictive pericarditis and pericardial resection in rheumatoid arthritis. Medicine (Baltimore). 1975 May; 54(3):261-70.
Score: 0.003
-
Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial. Am Heart J. 1995 Mar; 129(3):527-35.
Score: 0.003
-
Massive splenomegaly, pancytopenia and haemolytic anaemia in sarcoidosis. Acta Haematol. 1975; 53(4):230-40.
Score: 0.003
-
Conversion from immediate-release to extended-release diltiazem in angina pectoris. Clin Cardiol. 1994 Sep; 17(9):484-8.
Score: 0.003
-
Myocardial infarct artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3. Burroughs Wellcome Study Group. Am J Cardiol. 1993 Feb 15; 71(5):386-92.
Score: 0.003
-
Comparison of adrenergic beta-receptor antagonists in angina pectoris. Br Med J. 1973 Jan 20; 1(5846):138-42.
Score: 0.003
-
Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarction. Am J Cardiol. 1992 May 01; 69(14):1120-7.
Score: 0.003
-
Profunda femoral arteriovenous fistula after percutaneous arterial and venous catheterization. Br Heart J. 1971 Sep; 33(5):803-5.
Score: 0.003
-
Pericarditis after acute myocardial infarction. Br Med J. 1971 Apr 17; 2(5754):135-7.
Score: 0.003
-
Mechanisms of myocardial ischemia induced by epinephrine: comparison with exercise-induced ischemia. Psychosom Med. 1988 Jul-Aug; 50(4):381-93.
Score: 0.002
-
Effects of 1-epinephrine on hemodynamics and cardiac function in coronary disease: dose-response studies. Clin Pharmacol Ther. 1988 Mar; 43(3):308-16.
Score: 0.002
-
Doppler echocardiographic profiles in obstructive right and left atrial myxomas. J Am Coll Cardiol. 1987 Mar; 9(3):701-3.
Score: 0.002
-
Atenolol for ventricular ectopy: a dose-response study. Clin Pharmacol Ther. 1987 Jan; 41(1):118-23.
Score: 0.002
-
Kinetics of isosorbide dinitrate and relationships to pharmacological effects. Br J Clin Pharmacol. 1981 Jun; 11(6):579-89.
Score: 0.001
-
Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily. Am J Cardiol. 1981 May; 47(5):1123-7.
Score: 0.001
-
Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment. Br Med J. 1976 Jul 03; 2(6026):7-9.
Score: 0.001
-
Aortic valve incompetence and replacement in rheumatoid arthritis. Ann Rheum Dis. 1975 Aug; 34(4):312-20.
Score: 0.001
-
A comparative study of the activity of beta-adrenoceptor antagonists in man. Int J Clin Pharmacol Biopharm. 1975 Jul; 12(1-2):305-6.
Score: 0.001
-
Cardiovascular effects of weight reduction in obese patients with angina pectoris. Br Heart J. 1974 Sep; 36(9):854-8.
Score: 0.001
-
Plasma cortisol, urinary 17-hydroxycorticoids, and urinary vanilyl mandelic acid after acute myocardial infarction. Br Heart J. 1972 Oct; 34(10):992-7.
Score: 0.001
-
Lignocaine therapy for ventricular ectopic activity after acute myocardial infarction: a double-blind trial. Br Med J. 1971 Sep 18; 3(5776):668-70.
Score: 0.001